Keywords = urothelial carcinoma
| Number of Articles: 13 | ||||
| 1 | Immunohistochemical Expression of Estrogen Receptor Beta in Urothelial Carcinoma of the Urinary Bladder | |||
| Volume 6, Issue 2, July 2023, Page 241-248 | ||||
| Omnia M.M. Badawy; Sabah Ahmed Mohamed; Ahmed Mahmoud Hassan; Ghada Hosny Mohamed | ||||
| 2 | Prognostic significance of peroxisome proliferator-activated receptor-gamma (PPAR-γ) and Cyclin D1 in bladder urothelial carcinoma | |||
| Volume 29, Issue 1.2, January 2023, Page 160-173 | ||||
| Asmaa Hussein mohamed; Sabah mohamed Hanafy; Ahmed Mohamed Eliwa; mona salah fatthalla; Amira Elwan Mohammed | ||||
| 3 | Five Case Reports of Sarcomatoid Variant of Urothelial Carcinoma of the Bladder | |||
| Volume 4, Issue 2, June 2022, Page 18-22 | ||||
| Farouk Hachem; Hussein Abdallah; Ahmed Ibrahimi; Hachem Elsayegh; Yassine Nouini | ||||
| 4 | CD44 and p53 co-expression in high grade, muscle invasive bladder urothelial carcinoma with and without schistosomiasis | |||
| Volume 5, Issue 3, September 2021, Page 69-75 | ||||
| Rehab Sharaf El Deen; Osama Sayed; Wesam Moustafa | ||||
| 5 | Evaluation of pyruvate kinase M2 (PKM2) and epidermal growth factor receptor (EGFR) expression and their clinicopathologic significance in bladder urothelial carcinoma | |||
| Volume 5, Issue 3, September 2021, Page 141-152 | ||||
| Passant El-Sheikh; Maha Shamloula; Aliaa Atef; Dina El-Guindy | ||||
| 6 | Expression Of TIM-3 And CEACAM-1 In Bladder Urothelial Carcinoma ( Immunohistochmical And Histopathological Study ) | |||
| Volume 2, Issue 2, June 2021, Page 227-249 | ||||
| Abla Sayed Mahmoud; Sahar Ali Daoud; Wesam Ismail Moustafa; Osama Sayed; Badawia Bayoumi Ibrahim; Marwa Mohamed Sayed; Sarah Abdelrahman Mohammed | ||||
| 7 | GATA3 and CK5/6 Immunohistochemical Expression in Urothelial Carcinoma: Diagnostic, Biological and Prognostic Significance | |||
| Volume 3, Issue 2, April 2021, Page 1306-1315 | ||||
| Marwa Abdel Moneim El Kholy; Mohamed Yousef Ali; Ahmed Yousef Aboelsaad; Ahmed M. Abdel Gawad | ||||
| 8 | Significance of Expression of IMP3, PPARG & PD-L1 in Urothelial Carcinoma (Immunohistochemical Study) | |||
| Volume 38, Academic issue, February 2021, Page 112-127 | ||||
| Rasha El Sawi; Ebtehal Abdel Aal; Nehal Zafer; Hala Agina; Amr El-Sebaaie | ||||
| 9 | Immunohistochemical expression of β-Catenin in urinary bladder urothelial carcinoma | |||
| Volume 4, Issue 1, January 2021, Page 26-29 | ||||
| Fatma-Elzhraa A. Sherkawy; Amira A. Abdelnaby; Ghada S. Osman; Gamal A. Elsogheer; Eman M. Salaheldeen | ||||
| 10 | Review Article: Prognostic Value of CK5/6 Expression in Urinary Bladder Carcinoma | |||
| Volume 88, September, September 2020, Page 1441-1447 | ||||
| GEHAD R.A. EL-GAPHRAWY, M.Sc.; MARWA M. SERAG EL-DIEN, M.D.; SHEREEN F. MAHMOUD, M.D.; ASMAA G. ABDOU, M.D. | ||||
| 11 | Keratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma | |||
| Volume 87, December, December 2019, Page 4737-4746 | ||||
| SHAIMAA M.M. BEBARS, M.D.; WALAA ABD EL GAWAD GHANAM, M.D.; RASHA MOHAMED SAMIR SAID, M.D. | ||||
| 12 | AMBULANT FLEXIBLE CYSTOSCOPY FOR FOLLOW-UP OF Ta-T1 UROTHELIAL CARCINOMA OF THE URINARY BLADDER: PAIN PERCEPTION AND COST EFFECTIVE | |||
| Volume 45, Issue 2, August 2015, Page 429-433 | ||||
| AHMED M. KAMAL; MOHAMED WISHAHI; HANY H. NOUR; HOSSAM ELGANZOURY; AMR ELKHOULY; AHMED SALAH; AHMED I. KAMEL; AHMED G. ELBAZ; MAMDOUH ROUSHDY | ||||
| 13 | UROTHELIAL CARCINOMA OF THE URINARY BLADDER MIXED WITH SQUAMOUS DIFFERENTIATION OR SQUAMOUS CELL CARCINOMA IN AREAS WITH SCHISTOSOMIASIS IS SHOWING HIGH RISK OF RECURRENCE AND POOR SURVIVAL | |||
| Volume 44, Issue 2, August 2014, Page 467-473 | ||||
| MOHAMED WISHAHI; HOSSAM ELGANZOURY; AMR ELKHOULY; MOHAMED BADAWI | ||||
| | ||||
View on SCiNiTO